Testing AV-001 to protect the brain during hemodialysis
Part of Brain & nervous system, Kidney & urinary clinical trials.
This study tests a new medicine called AV-001 to see if it can protect the brain from damage caused by hemodialysis. If you qualify, you may help find a way to reduce thinking and memory problems linked to dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and be a man or a woman who is not pregnant.
- You need to have been on hemodialysis for at least 3 months.
- You must go to hemodialysis 3 times every week.
- You must be able to have an MRI scan (no metal implants, pacemaker, etc.).
- You should not have severe memory problems or a diagnosis of dementia.
- You cannot have had a stroke in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device that uses light to check the health of your AV access (the blood vessel connection used for dialysis) without touching it. It may help doctors spot problems early.
This study looks at how blood vessel problems in the brain and thinking (cognition) are related in people who are on long-term hemodialysis for kidney failure. By joining, you help doctors learn how to better protect brain health in dialysis patients.
This study tests whether a virtual reality program can help improve thinking and memory problems often seen in people on dialysis. If you are on dialysis and can use a VR headset, you may be able to join and potentially benefit from this new approach.
This trial tests whether taking preventive antibiotics (or a placebo sugar pill) can lower the risk of infections in people who receive hemodialysis through a catheter. It may help protect you from serious catheter-related infections, but you must be able to follow the study’s medicine and consent rules.
This study tests whether an “AV graft” implant works safely and well for people with end-stage kidney disease who need hemodialysis. It may help your dialysis access last and work better, compared with current expectations for AV grafts.
This study is testing a new monitoring tool to keep an eye on the health of the fistula used for dialysis. It aims to catch problems early so you can avoid complications.
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.